Results 281-300 of 19,912 for drugs

Written Answers — Department of Justice and Equality: Drug Dealing (17 Jan 2024)

Thomas Gould: 1134. To ask the Tánaiste and Minister for Justice and Equality the number of incidents of drug-related intimidation reported to gardaí in 2023, by county. [1706/24]

Written Answers — Department of Health: Misuse of Drugs (17 Jan 2024)

Neasa Hourigan: 1499. To ask the Minister for Health if the HSE is aware of the presence of the semi-synthetic cannabinoid, HHC or hexahydrocannabinol, in Ireland; if so, when the HSE was first made aware of its presence; and if he will make a statement on the matter. [56526/23]

Written Answers — Department of Health: Medicinal Products (17 Jan 2024) See 2 other results from this answer

Seán Sherlock: ...for Health the criteria for a medicine reimbursement application to be considered by the HSE’s products committee for reimbursement; the criteria for a medicine to be considered by the HSE’s Drugs Group; and if he will make a statement on the matter. [56569/23]

Written Answers — Department of Health: Medicinal Products (17 Jan 2024) See 1 other result from this answer

Pádraig O'Sullivan: 1513. To ask the Minister for Health if the additional €92 million allocated to health as part of the revised estimates volume will include funding for new drugs in 2024; how much of that funding will be allocated to new drugs; if he will provide further information and clarity on the matter; and if he will make a statement on the matter. [56612/23]

Written Answers — Department of Health: Health Services (17 Jan 2024)

Stephen Donnelly: ...on an administrative basis. Medical cards awarded on end-of-life grounds are never re-assessed by the HSE thereby providing reassurance and comfort to patients and their families. Since 2022, under the Drugs Payment Scheme (DPS), no individual or family pays more than €80 a month towards the cost of approved prescribed medicines. The DPS is not means tested and is available to...

Written Answers — Department of Health: Medicinal Products (17 Jan 2024) See 1 other result from this answer

John Lahart: 1548. To ask the Minister for Health what additional amount has been allocated to orphan/new drugs for 2024; and if he will make a statement on the matter. [56756/23]

Written Answers — Department of Health: Health Services (17 Jan 2024)

Stephen Donnelly: ...diabetes mellitus; parkinsonism; epilepsy; phenylketonuria; haemophilia; spina bifida; hydrocephalus; and conditions arising from the use of Thalidomide. Under the LTI Scheme, patients receive drugs, medicines, and medical and surgical appliances directly related to the treatment of their illness, free of charge. While there are currently no plans to extend the list of conditions...

Written Answers — Department of Health: Healthcare Policy (17 Jan 2024) See 2 other results from this answer

Fergus O'Dowd: 1580. To ask the Minister for Health if he expects ozempic to be added to the GMS list for weight loss; the reason the drug is not available under the drug payments, considering the considerable impact it is having on weight and the associated positive effect it is having on health, thus reducing the long term requirement for other services linked to obesity and weight problems; and if he...

Written Answers — Department of Health: Healthcare Policy (17 Jan 2024) See 1 other result from this answer

Anne Rabbitte: 1589. To ask the Minister for Health the stage of approval the drug tabrecta is at; the timeline for approval; and if he will make a statement on the matter. [57081/23]

Written Answers — Department of Health: Healthcare Policy (17 Jan 2024)

Stephen Donnelly: ...for Medical Use Register for the purpose of treating their patients is confidential and will not be made public. The products available to MCAP patients are defined as "specified controlled drugs" S.I. No. 262/2019 - Misuse Of Drugs (Prescription And Control Of Supply Of Cannabis For Medical Use) Regulations 2019, and are contained in Schedule 1 of the Regulations as set out below and are...

Written Answers — Department of Health: Health Services (17 Jan 2024)

Stephen Donnelly: The Health Service Executive (HSE) has statutory responsibility for pricing and reimbursement decisions under the community drug schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. Therefore, this matter has been referred to the HSE for attention and direct reply to the Deputy.

Written Answers — Department of Health: Departmental Data (17 Jan 2024) See 1 other result from this answer

Colm Burke: 1634. To ask the Minister for Health the number of prescriptions issued for fentanyl as part of a public drug scheme or in a HSE hospital, psychiatric facility or primary care setting and by a private GP from 2011 to date in 2024, in tabular form. [1055/24]

Written Answers — Department of Health: Misuse of Drugs (17 Jan 2024)

Colm Burke: 1638. To ask the Minister for Health if his attention has been drawn to reports of increasing the misuse of fentanyl (details supplied); the measures that the Department is taking to tackle fentanyl misuse; and if he will make a statement on the matter. [1059/24]

Written Answers — Department of Health: Departmental Schemes (17 Jan 2024)

Stephen Donnelly: ...diabetes mellitus; parkinsonism; epilepsy; phenylketonuria; haemophilia; spina bifida; hydrocephalus; and conditions arising from the use of Thalidomide. Under the LTI Scheme, patients receive drugs, medicines, and medical and surgical appliances directly related to the treatment of their illness, free of charge. Gestational diabetes is not a permanent or long-term illness and is,...

Written Answers — Department of Health: Misuse of Drugs (17 Jan 2024)

Colm Burke: 1645. To ask the Minister for Health if his attention has been drawn to alerts issued by the HSE on ketamine (details supplied); the measures that his Department is taking to tackle ketamine use; and if he will make a statement on the matter. [1099/24]

Written Answers — Department of Health: Traveller Community (17 Jan 2024) See 1 other result from this answer

Hildegarde Naughton: The principal officer in the Drugs Policy and Social Inclusion Unit in the Department of Health is responsible for Traveller health. The Mental Health Unit in the Department is responsible for Traveller mental health. The HSE is responsible for the provision of healthcare services for Travellers. This is overseen by the National Social Inclusion Office. The HSE has established the...

Written Answers — Department of Health: Addiction Treatment Services (17 Jan 2024) See 1 other result from this answer

Peadar Tóibín: 1721. To ask the Minister for Health the number of babies born with addiction to drugs or alcohol in each of the past ten years. [1532/24]

Written Answers — Department of Health: Departmental Schemes (17 Jan 2024)

Stephen Donnelly: ...diabetes mellitus; parkinsonism; epilepsy; phenylketonuria; haemophilia; spina bifida; hydrocephalus; and conditions arising from the use of Thalidomide. Under the LTI Scheme, patients receive drugs, medicines, and medical and surgical appliances directly related to the treatment of their illness, free of charge. Gestational diabetes is not a permanent or long-term illness and is,...

Written Answers — Department of Health: Departmental Schemes (17 Jan 2024)

Stephen Donnelly: ...diabetes mellitus; parkinsonism; epilepsy; phenylketonuria; haemophilia; spina bifida; hydrocephalus; and conditions arising from the use of Thalidomide. Under the LTI Scheme, patients receive drugs, medicines, and medical and surgical appliances directly related to the treatment of their illness, free of charge. While there are currently no plans to extend the list of conditions...

Written Answers — Department of Health: Departmental Schemes (17 Jan 2024) See 1 other result from this answer

Seán Canney: 1747. To ask the Minister for Health if a person on the drugs payment scheme gets two sets of 28-day medication in the one calendar month, if they are obliged to the pay the €80 a second time; and if he will make a statement on the matter. [1662/24]